Full name
LEENLIFE PHARMAFOODS SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
10.89.Z - Production of other food products, not elsewhere classified
10.92.Z - Production of prepared pet food
20.42.Z - Manufacture of cosmetics and toilet preparations
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
46.90.Z - Non-specialized wholesale trade
47.91.Z - Intermediary retail sale, non-specialized
71.20.A - Food quality testing and analysis
72.11.Z - Scientific research and development activities
77.40.Z - Leasing of intellectual property and similar products, excluding works protected by copyright
2020 | 2021 | 2022 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Gross profit (loss) | -12,4 | 0,4 | 0,5 | 25 |
EBITDA | -12,8 | 0 | 0 | 0 |
Short time liabilities | 1,2 | 1,2 | 1,2 | 0 |
Equity capital | -3,3 | -2,9 | 10,6 | 468,5 |
Operating profit (EBIT) | -12,8 | 0 | 0 | 0 |
Assets | 6 | 6,4 | 11,9 | 86,1 |
Net profit (loss) | -12,4 | 0,4 | 0,5 | 25 |
Cash | 0 | 0 | 0 | 0 |
Net income from sale | 0 | 0 | 0 | 0 |
Liabilities and provisions for liabilities | 9,3 | 9,3 | 1,2 | -86,7 |
Working assets | 6 | 6,4 | 6,9 | 7,7 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 379,2 | -13,6 | 4,6 | 18,2 |
Equity capital to total assets | -54,8 | -45,3 | 89,6 | 134,9 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 2 147 483 648 | 2 147 483 648 | 2 147 483 648 | 0 |
Current financial liquidity indicator | 0.6461242437362671 | 0.6884293556213379 | 5.5814666748046875 | 4,9 |
Net dept to EBITDA | 0 | 0 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane